Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004048436 | SCV002608943 | uncertain significance | not specified | 2022-09-04 | criteria provided, single submitter | clinical testing | The p.P1046L variant (also known as c.3137C>T), located in coding exon 17 of the NPAT gene, results from a C to T substitution at nucleotide position 3137. The proline at codon 1046 is replaced by leucine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003099226 | SCV003251071 | benign | not provided | 2025-01-15 | criteria provided, single submitter | clinical testing |